# Danaher completes acquisition of Cepheid

Danaher Corporation completed its acquisition of Cepheid, with Cepheid becoming an indirect wholly owned subsidiary of Danaher. Each share of Cepheid common stock was converted into the right to receive $53.00 per share in cash.

- Type: Acquisition
- Announced: 2016-11-04
- Where: United States
- Status: completed
- Products: molecular diagnostics
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Phenomenex](https://endata.com/companies/1494.md) (target)
- [Danaher](https://endata.com/companies/16260.md) (acquirer)
- [Cepheid](https://endata.com/companies/19924.md) (target)

## Sources

- [investors.danaher.com](https://investors.danaher.com/2016-11-04-Danaher-Completes-Acquisition-Of-Cepheid), 2016-11-04: "Danaher Corporation announced that today it completed its acquisition of Cepheid."
- [prnewswire.com](https://www.prnewswire.com/news-releases/danaher-completes-acquisition-of-cepheid-300357972.html), 2016-11-04: "Danaher Corporation announced that today it completed its acquisition of Cepheid."
- [marketscreener.com](https://www.marketscreener.com/quote/stock/DANAHER-CORPORATION-12295/news/Danaher-Corp-completed-the-acquisition-of-Phenomenex-Inc-35260434/), 2016-11-29: "Danaher Corp. (NYSE:DHR) completed the acquisition of Phenomenex Inc. in November 2016."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.